Cargando...
Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases
Tamoxifen is frequently used as adjuvant treatment in premenopausal patients with hormone receptor-positive early breast cancer. According to guidelines, the use of nonhormonal barrier contraception is recommended during tamoxifen treatment and up to 3 months after its interruption prior to attempti...
Gardado en:
| Publicado en: | Breast Care (Basel) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
S. Karger GmbH
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7204783/ https://ncbi.nlm.nih.gov/pubmed/32398983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501473 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|